Fucoidan alleviates the hepatorenal syndrome through inhibition organic solute transporter α/β to reduce bile acids reabsorption
The high levels of bile acids are a critical factor in hepatorenal syndrome. Organic solute transporter α/β (Ostα/β) participate in bile acids reabsorption in the kidney. Fucoidan has the great potential in protecting against liver and kidney injury. However, whether Ostα/β increase bile acids reabs...
Saved in:
Main Authors: | Xiaojuan Zhao (Author), Ting Yang (Author), Jiayan Zhou (Author), Yanli Chen (Author), Qian Shen (Author), Jiankang Zhang (Author), Qianqian Qiu (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Fucoidan alleviates the mitochondria and endoplasmic reticulum stresses in ischemic rat livers
by: Chérifa Slim, et al.
Published: (2022) -
Fucoidans
Published: (2021) -
Hepatorenal Syndrome
by: Pınar Zeyneloğlu
Published: (2012) -
Antitumor effect and molecular mechanism of fucoidan in NSCLC
by: Xiaohan Chen, et al.
Published: (2021) -
Cardiorenal and hepatorenal syndrome
by: Anand Bhutada, et al.
Published: (2018)